950 related articles for article (PubMed ID: 33715385)
1. Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19.
Cai Q; Yin F; Hao L; Jiang W
Stem Cells Dev; 2021 May; 30(9):459-472. PubMed ID: 33715385
[TBL] [Abstract][Full Text] [Related]
2. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
Cheng X; Jiang M; Long L; Meng J
Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
[No Abstract] [Full Text] [Related]
3. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
[TBL] [Abstract][Full Text] [Related]
4. The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19.
Gu J; Zhao Q; Han Z; Han Z
Curr Stem Cell Res Ther; 2021; 16(3):277-285. PubMed ID: 32729428
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
Zayed M; Iohara K
Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.
Yadav P; Vats R; Bano A; Bhardwaj R
Life Sci; 2020 Dec; 263():118588. PubMed ID: 33049279
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19.
Li JP; Wu KH; Chao WR; Lee YJ; Yang SF; Chao YH
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897770
[TBL] [Abstract][Full Text] [Related]
8. Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions.
Khanh VC; Fukushige M; Chang YH; Hoang NN; Yamashita T; Obata-Yasuoka M; Hamada H; Osaka M; Hiramatsu Y; Ohneda O
Stem Cells Dev; 2021 Aug; 30(15):758-772. PubMed ID: 34074129
[TBL] [Abstract][Full Text] [Related]
9. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
Can A; Coskun H
Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.
Verma YK; Verma R; Tyagi N; Behl A; Kumar S; Gangenahalli GU
Stem Cell Rev Rep; 2021 Feb; 17(1):113-131. PubMed ID: 32920752
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside.
Sahu KK; Siddiqui AD; Cerny J
Lab Med; 2021 Jan; 52(1):24-35. PubMed ID: 32729620
[TBL] [Abstract][Full Text] [Related]
12. Post-COVID pulmonary fibrosis: therapeutic efficacy using with mesenchymal stem cells - How the lung heals.
Vishnupriya M; Naveenkumar M; Manjima K; Sooryasree NV; Saranya T; Ramya S; Harysh Winster S; Paulpandi M; Balachandar V; Arul N
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2748-2751. PubMed ID: 33829461
[TBL] [Abstract][Full Text] [Related]
13. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
Al-Khawaga S; Abdelalim EM
Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications.
Chen L; Qu J; Kalyani FS; Zhang Q; Fan L; Fang Y; Li Y; Xiang C
Cell Mol Life Sci; 2022 Feb; 79(3):142. PubMed ID: 35187617
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell therapy for severe COVID-19.
Shi L; Wang L; Xu R; Zhang C; Xie Y; Liu K; Li T; Hu W; Zhen C; Wang FS
Signal Transduct Target Ther; 2021 Sep; 6(1):339. PubMed ID: 34497264
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cell research progress for the treatment of COVID-19.
Yao D; Ye H; Huo Z; Wu L; Wei S
J Int Med Res; 2020 Sep; 48(9):300060520955063. PubMed ID: 32972277
[TBL] [Abstract][Full Text] [Related]
17. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments.
Gurunathan S; Kang MH; Kim JH
Front Immunol; 2021; 12():716407. PubMed ID: 34394121
[TBL] [Abstract][Full Text] [Related]
18. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
Pinheiro MM; Fabbri A; Infante M
Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review.
Li J; Wang X; Li N; Jiang Y; Huang H; Wang T; Lin Z; Xiong N
Curr Gene Ther; 2020; 20(4):285-288. PubMed ID: 32867652
[TBL] [Abstract][Full Text] [Related]
20. MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment.
Wang XY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4537-4538. PubMed ID: 32373992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]